There’s no way around it: if Congress gives up on ending surprise medical billing, they’re choosing private equity firms over patients. For private equity-backed physician staffing firms, surprise medical bills aren’t an accident—they’re a key element of the business model. Wall Street powerhouses like KKR and Blackstone see surprise billing as a lucrative opportunity to turbocharge their bottom line—all at the expense of patients and their families.

That’s why there’s consensus across the country that Congress needs to step up and pass a bipartisan solution to ending surprise medical billing for good.